Drugs / JW0301
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05433844 | Jun → Aug 2022 | — | JW Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JW0301 | “Test Drug: single administration of JW0301 Reference Drug: single administration of C2105” NCT05433844 ↗ |